Microsoft’s MAI‑DxO outperforms doctors on complex case sets
Key Points: 1. In head to head testing on 304 NEJM Clinical Case Records the debate driven system solved 85.5 percent of ...
Key Points: 1. In head to head testing on 304 NEJM Clinical Case Records the debate driven system solved 85.5 percent of ...
Imfinzi Combo Cuts Gastric Cancer Risk by Twenty Nine Percent Earlier this week at the American Society of Clinical Oncology ...
Imfinzi Combo Shows Promise in Early Gastric Cancer At the American Society of Clinical Oncology meeting earlier this week, investigators ...
Key points:1. The Food and Drug Administration is preparing to launch an agency wide generative artificial intelligence system by the ...
Food and Drug Administration to Fully Integrate Generative Artificial Intelligence by JuneThe Food and Drug Administration is diving headfirst into ...
Key Points: 1. FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial ...
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
1. In this evaluation of clinical trial cost of newly FDA-approved therapeutics, trials without control arms and with small numbers ...
1. This study, which identified clinical trials that the FDA deemed to have committed significant violations, determined that fewer than ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.